iShares Health Innovation Active ETF Rating $28.40 -0.16 (-0.56%) As of 09:51 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Health Innovation Active ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BMED Aggregate RatingModerate Buy 2.64Holdings in BMED have an aggregate rating of Moderate Buy based on 441 analyst ratings issued in the past year covering 20 companies (64.0% of the portfolio).BMED Aggregate Price Target$28.560.56% UpsideHigh Prediction$28.56Average Prediction$28.56Low Prediction$28.56Holdings in BMED have an aggregate price target of $28.56 and a range of $28.56 to $28.56 covering 20 companies (64.0% of the portfolio).BMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Health Innovation Active ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 20 BMED Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.60%MRKMerck & Co., Inc.$116.07-2.5%4.5869 of 5 stars2.68$128.18 10.4%19Positive NewsOptions Volume5.25%GILDGilead Sciences$124.94-0.5%4.9211 of 5 stars2.86$156.93 25.6%29Positive NewsAnalyst Revision5.06%JNJJohnson & Johnson$236.50-1.8%4.4237 of 5 stars2.74$253.04 7.0%27Positive NewsInsider Trade4.80%EWEdwards Lifesciences$85.06-0.1%3.6247 of 5 stars2.81$95.96 12.8%27Positive News3.69%BIIBBiogen$198.23-0.9%3.6636 of 5 stars2.55$217.26 9.6%293.69%WATWaters$354.67-0.2%3.2223 of 5 stars2.71$394.56 11.2%213.57%AMGNAmgen$357.73+0.7%3.8187 of 5 stars2.48$354.12 -1.0%31Positive NewsAnalyst Forecast3.15%CRLCharles River Laboratories International$189.77+1.2%2.603 of 5 stars2.63$208.50 9.9%163.01%VRTXVertex Pharmaceuticals$450.16+1.2%4.6443 of 5 stars2.88$555.91 23.5%25Positive News2.86%TMOThermo Fisher Scientific$469.68+0.1%4.8977 of 5 stars2.88$608.95 29.7%25Positive NewsAnalyst Revision2.82%DHRDanaher$180.100.0%4.7159 of 5 stars2.84$233.61 29.7%25News CoveragePositive News2.76%MTDMettler-Toledo International$1,142.49+1.0%3.698 of 5 stars2.46$1,408.55 23.3%132.69%MRNAModerna$51.45+3.1%1.3316 of 5 stars1.83$36.60 -28.9%182.48%DXCMDexCom$74.75-0.8%4.4329 of 5 stars2.92$84.83 13.5%26Positive NewsAnalyst Forecast2.39%PFEPfizer$26.36+0.6%3.8336 of 5 stars2.25$28.82 9.3%20Positive NewsAnalyst Downgrade2.38%BRKRBruker$53.88-0.7%2.6865 of 5 stars2.40$51.31 -4.8%15Positive News2.07%NBIXNeurocrine Biosciences$157.15-1.6%3.8583 of 5 stars2.87$187.52 19.3%231.97%GSKGSK$53.07+0.1%2.8531 of 5 stars2.00$53.00 -0.1%10Dividend Cut1.93%TECHBio-Techne$55.60+3.0%3.7926 of 5 stars2.67$65.15 17.2%151.84%UNHUnitedHealth Group$409.84+0.3%4.2036 of 5 stars2.78$407.17 -0.7%27Positive NewsOptions Volume This page (NYSEARCA:BMED) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Health Innovation Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Health Innovation Active ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
